NCOA4-RET Fusion FISH Probe
The NCOA4-RET Fusion FISH Probe is used to confirm a fusion of the NCOA4 and RET genes. The fusion of the NCOA4 and RET genes has been associated with Thyroid Carcinoma, Thyroid Carcinoma, Thyroid Carcinoma, and Thyroid Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| NCOA4-RET-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| NCOA4-RET-20-RERE | 20 (40 μL) | 200 μL |
|
|
| NCOA4-RET-20-REOR | 20 (40 μL) | 200 μL |
|
|
| NCOA4-RET-20-REGO | 20 (40 μL) | 200 μL |
|
|
| NCOA4-RET-20-REGR | 20 (40 μL) | 200 μL |
|
|
| NCOA4-RET-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| NCOA4-RET-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| NCOA4-RET-20-OROR | 20 (40 μL) | 200 μL |
|
|
| NCOA4-RET-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| NCOA4-RET-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| NCOA4-RET-20-GORE | 20 (40 μL) | 200 μL |
|
|
| NCOA4-RET-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| NCOA4-RET-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| NCOA4-RET-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| NCOA4-RET-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| NCOA4-RET-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| NCOA4-RET-20-GROR | 20 (40 μL) | 200 μL |
|
|
| NCOA4-RET-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| NCOA4-RET-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| NCOA4-RET-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| NCOA4-RET-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| NCOA4-RET-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| NCOA4-RET-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| NCOA4-RET-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| NCOA4-RET-20-AQAQ | 20 (40 μL) | 200 μL |
|
RET Gene Summary
This gene encodes a transmembrane receptor and member of the tyrosine protein kinase family of proteins. Binding of ligands such as GDNF (glial cell-line derived neurotrophic factor) and other related proteins to the encoded receptor stimulates receptor dimerization and activation of downstream signaling pathways that play a role in cell differentiation, growth, migration and survival. The encoded receptor is important in development of the nervous system, and the development of organs and tissues derived from the neural crest. This proto-oncogene can undergo oncogenic activation through both cytogenetic rearrangement and activating point mutations. Mutations in this gene are associated with Hirschsprung disease and central hypoventilation syndrome and have been identified in patients with renal agenesis. [provided by RefSeq, Sep 2017]
Gene Name: Ret Proto-oncogene
Chromosome: CHR10: 43572516 -43625797
Locus: 10q11.21
NCOA4 Gene Summary
This gene encodes an androgen receptor coactivator. The encoded protein interacts with the androgen receptor in a ligand-dependent manner to enhance its transcriptional activity. Chromosomal translocations between this gene and the ret tyrosine kinase gene, also located on chromosome 10, have been associated with papillary thyroid carcinoma. Alternatively spliced transcript variants have been described. Pseudogenes are present on chromosomes 4, 5, 10, and 14. [provided by RefSeq, Feb 2009]
Gene Name: Nuclear Receptor Coactivator 4
Chromosome: CHR10: 51565107 -51590734
Locus: 10q11.22
Gene Diseases
The NCOA4 RET Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Thyroid Carcinoma |
| Thyroid Carcinoma |
| Thyroid Carcinoma |
| Thyroid Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|